These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9468552)

  • 1. The expression of MMP-2 and TIMP-2 in patients with colorectal adenocarcinoma invaded to the submucosal and proper muscle layer.
    Mukai M; Sadahiro S; Tokunaga N; Ishizu K; Ito I; Kameya T; Ishikawa K; Iwase H; Suzuki T; Kimura T; Ishida H; Tajima T; Makuuchi H
    Oncol Rep; 1998; 5(2):335-40. PubMed ID: 9468552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinoma: correlation with liver metastasis.
    Mukai M; Sadahiro S; Tokunaga N; Ishizu K; Ito I; Kameya T; Ishikawa K; Iwase H; Suzuki T; Ishida H; Tajima T; Makuuchi H
    Oncol Rep; 1999; 6(5):969-73. PubMed ID: 10425288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
    Kikuchi R; Noguchi T; Takeno S; Kubo N; Uchida Y
    Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
    Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
    J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
    Parsons SL; Watson SA; Collins HM; Griffin NR; Clarke PA; Steele RJ
    Br J Cancer; 1998 Dec; 78(11):1495-502. PubMed ID: 9836483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
    J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
    Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis.
    Li BH; Zhao P; Liu SZ; Yu YM; Han M; Wen JK
    World J Gastroenterol; 2005 May; 11(20):3046-50. PubMed ID: 15918187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.
    Morán A; Iniesta P; García-Aranda C; De Juan C; Díaz-López A; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Balibrea JL; Benito M
    Oncol Rep; 2005 Jan; 13(1):115-20. PubMed ID: 15583811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.
    Ring P; Johansson K; Höyhtyä M; Rubin K; Lindmark G
    Br J Cancer; 1997; 76(6):805-11. PubMed ID: 9310250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
    Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
    Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.